Individual variability in responses to nicotine

Abstract

Individual variability in acute responses to nicotine, which may be defined as variable magnitude of effects following controlled dosing, is generally attributed to stable characteristics of tobacco users such as genetic/constitutional factors or to chronic behavioral factors (e.g., long-term use of other drugs). Often overlooked, however, is that such variability may also be due to the transient influence of the situational factors in which people consume nicotine, such as acute stress or physical activity. Results of selected studies from the author's laboratory provide examples of each of these sources of variability in nicotine responding on subjective, behavioral, and physiological measures. All studies used a nasal spray method of nicotine dosing or controlled smoking (paced puffing) to control acute nicotine exposure, an essential methodological feature of any research on individual differences in acute responses to nicotine. As an example of genetic/constitutional factors, gender differences in nicotine responding have begun to receive some attention, with few differences emerging. However, females may be more responsive than males to nonnicotine stimuli associated with smoking (e.g., sight and taste of smoke). In terms of chronic behavioral factors, long-term use of nicotine produces attenuation of most subjective and some behavioral effects of nicotine, reflecting chronic tolerance, and the possibility that chronic use of other drugs may alter responses to nicotine (i.e., cross-tolerance or cross-sensitization) deserves greater study. Of particular emphasis in this review is the modulating influence of acute situational factors on nicotine responding. Human studies have shown that magnitude of nicotine's subjective effects may depend on the predrug subjective state, level of physical activity vs. rest, and concurrent acute intake of other drugs, among other situational factors. Proper consideration of these situational factors may reveal the greatest source of individual variability in responding to nicotine and clarify the impact of more stable genetic/constitutional or chronic environmental factors.

Nicotinic acetylcholine receptors as targets for antidepressants

“…110 Similar state-dependent effects of nicotinic receptor modulating drugs are common and have been recently reviewed. 114 Third, while suggestive, the clinical data regarding the putative mood modulating effects of mecamylamine remain preliminary due to the small number of patients tested so far. 102,103 Thus, further rigorous investigation in more diverse affective disorder popu-lations is needed before definitive conclusions can be drawn.…”

An acute dose, randomized trial of the effects of CDP-Choline on Mismatch Negativity (MMN) in healthy volunteers stratified by deviance detection level

“…These factors, as well as genetic influences, and inter-subject differences in smoker vs. nonsmoker status, pre-drug state, and functional level are also significant sources of individual variability in nicotine response (Gilbert and Gilbert 1995;Kupferschmidt et al 2010;Li et al 2009;Perkins 1995;Perkins 2009;Poltavski and Petros 2005). Frequently shown in animal models and in human studies, baseline-dependent differences have influenced behavioural, cognitive, and subjective mood responses to nicotine (Perkins 1999).…”

Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function

“…Experimental data from our (17) and other (14,18,19,26) laboratories suggest that even brief exposures to SHS cause marked changes in thyroid hormone secretion, platelet aggregation, endothelial function, arterial pressure waveform, inflammatory markers, as well as other hemodynamic alterations involved in the development of ischemic heart disease. At least some of these effects appear to be more pronounced in men compared with women (14,20), but the mechanism underlying this phenomenon has yet to be elucidated. We conducted a randomized single-blind crossover study to investigate the sexspecific effects of a 1-h exposure to SHS on gonadal and thyroid hormones, inflammatory cytokines, and specific parameters of vascular function.…”